SCHEMBL17774607

SCHEMBL17774607

Cc1ccc2c(N)c(S(=O)(=O)O)cc(O)c2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NT5E P21589 2/20 0.47
▸ MPL P40238 2/20 0.43
▸ ALDH1A1 P00352 7/20 0.42
▸ KDM4E B2RXH2 5/20 0.42
▸ HSD17B10 Q99714 3/20 0.40
▸ MEN1 O00255 3/20 0.40
▸ MAPT P10636 3/20 0.40
▸ KMT2A Q03164 3/20 0.40
▸ RECQL P46063 2/20 0.40
▸ ALOX15 P16050 2/20 0.40
▸ HPGD P15428 2/20 0.40
▸ CYP2C9 P11712 2/20 0.40
▸ CYP3A4 P08684 2/20 0.40
▸ TP53 P04637 1/20 0.40
▸ APP P05067 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ THRB P10828 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17774606 0.94 NT5E (0.43) NT5EMPLALDH1A1KDM4EHSD17B10
SCHEMBL9789611 0.87 NT5E (0.61) NT5EMPLALDH1A1KDM4EHSD17B10
SCHEMBL28306586 0.80 NT5E (0.44) NT5EMPLALDH1A1KDM4EHSD17B10
SCHEMBL1891262 0.80 MPL (0.57) NT5EMPLALDH1A1MEN1MAPT
SCHEMBL16454269 0.77 ALDH1A1 (0.42) NT5EMPLALDH1A1KDM4EHSD17B10
SCHEMBL17779171 0.77 ENPP2 (0.48) NT5EALDH1A1CYP2C19CASP6GAA
SCHEMBL10579215 0.74 KMT2A (0.43) NT5EMPLALDH1A1MEN1MAPT
SCHEMBL8819113 0.72 NT5E (0.44) NT5EMPLALDH1A1KDM4EHSD17B10
SCHEMBL27676543 0.72 NT5E (0.42) NT5EALDH1A1KDM4EHSD17B10MAPT
SCHEMBL17779172 0.72 ENPP2 (0.49) NT5EALDH1A1CYP2C19CASP6GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9872822-B2 Process for dyeing in the presence of oxidation bases comprising at least one sulfonic, sulfonamide, sulfone, amid or acid group and a metal catalyst, device and ready-to-use composition L'OREAL (FR) 2018-01-23 — — US disclosed
US-20160143826-A1 PROCESS FOR DYEING IN THE PRESENCE OF OXIDATION BASES COMPRISING AT LEAST ONE SULFONIC, SULFONAMIDE, SULFONE, AMID OR ACID GROUP AND A METAL CATALYST, DEVICE AND READY-TO-USE COMPOSITION L'OREAL (FR) 2016-05-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160143826-A1 PROCESS FOR DYEING IN THE PRESENCE OF OXIDATION BASES COMPRISING AT LEAST ONE SULFONIC, SULFONAMIDE, SULFONE, AMID OR ACID GROUP AND A METAL CATALYST, DEVICE AND READY-TO-USE COMPOSITION KRT18, ARSA, SQOR NT5E 3046/4885MPL 4883/4885ALDH1A1 440/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback